Present Status and Problems on Molecular Targeted Therapy of Cancer
Author:
Publisher
Korean Cancer Association
Subject
Cancer Research,Oncology
Link
http://www.e-crt.org/upload/pdf/crt-44-1.pdf
Reference50 articles.
1. Mechanisms of Disease: oncogene addiction—a rationale for molecular targeting in cancer therapy
2. Impact of Epidermal Growth Factor Receptor and KRAS Mutations on Clinical Outcomes in Previously Untreated Non–Small Cell Lung Cancer Patients: Results of an Online Tumor Registry of Clinical Trials
3. Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
4. Phase III randomized, open-label, multicenter trial (BRIM3) comparing BRAF inhibitor vemurafenib with dacarbazine (DTIC) in patients with V600EBRAF-mutated melanoma.
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Revolutionizing in vivo therapy with CRISPR/Cas genome editing: breakthroughs, opportunities and challenges;Frontiers in Genome Editing;2024-02-01
2. BRCA Mutations and PARP Inhibitors in Breast and/or Ovarian Cancer Patients;International Journal Of Pharmaceutical Research And Allied Sciences;2021
3. Aromatic Linkers Unleash the Antiproliferative Potential of 3‐Chloropiperidines Against Pancreatic Cancer Cells;ChemMedChem;2020-09-15
4. Combining PARP Inhibition with Platinum, Ruthenium or Gold Complexes for Cancer Therapy;ChemMedChem;2020-09-10
5. Pleuromutilin Inhibits Proliferation and Migration of A2780 and Caov-3 Ovarian Carcinoma Cells and Growth of Mouse A2780 Tumor Xenografts by Down-Regulation of pFAK2;Medical Science Monitor;2020-01-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3